About
Vildagliptin/Metformin is a fixed-dose combination medication used for the management of type 2 diabetes mellitus. It combines two distinct oral antihyperglycemic agents with complementary mechanisms of action. Vildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that enhances the body's natural ability to control blood glucose by increasing the levels of active incretin hormones (GLP-1 and GIP). These hormones stimulate insulin release from pancreatic beta cells and suppress glucagon secretion from alpha cells, particularly in a glucose-dependent manner. Metformin, a biguanide, primarily reduces hepatic glucose production, decreases intestinal absorption of glucose, and improves insulin sensitivity by increasing peripheral glucose uptake and utilization. This dual action provides comprehensive glycemic control, targeting multiple pathophysiological defects in type 2 diabetes, and is often prescribed when monotherapy with metformin or a sulfonylurea does not achieve adequate control.
Uses
- Management of type 2 diabetes mellitus.
- As an adjunct to diet and exercise.
- When metformin monotherapy is insufficient.
- To improve glycemic control in adults.
Directions For Use
Take orally, usually twice daily with meals, as directed by your physician. Swallow the tablet whole.
Benefits
- Dual mechanism of action for comprehensive control.
- Significant reduction in HbA1c levels.
- Low risk of hypoglycemia (due to vildagliptin component).
- Improves both fasting and post-meal glucose.
- May lead to modest weight loss (due to metformin).
- Enhances natural insulin secretion.
Side Effects
- Nausea and vomiting
- Diarrhea
- Abdominal pain
- Headache
- Dizziness
- Nasopharyngitis
- Tremor
- Fatigue
- Hypoglycemia (less common)
- Lactic acidosis (rare, serious)
- Metallic taste
- Vitamin B12 deficiency (long-term)
Safety Measures
- Alcohol - Excessive alcohol intake increases the risk of lactic acidosis, a serious side effect of metformin. Limit or avoid alcohol.
- Pregnancy - Generally not recommended during pregnancy. Insulin therapy is usually preferred. Consult your doctor.
- Breastfeeding - Both components may pass into breast milk. Not recommended during breastfeeding. Consult your doctor.
- Liver - Contraindicated in severe liver impairment due to increased risk of lactic acidosis with metformin. Use with caution in moderate impairment.
- Kidney - Contraindicated in severe kidney impairment (eGFR <30 mL/min/1.73m²) due to metformin accumulation and lactic acidosis risk. Dose adjustment needed for moderate impairment.
- Lung - Severe acute or chronic lung disease can increase the risk of lactic acidosis due to tissue hypoxia. Use with caution and monitor.
Disclaimer
MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!